Skip to main content
Clinical Trials/NCT02659345
NCT02659345
Completed
Not Applicable

Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients Undergoing Chemotherapy Treatment

Case Comprehensive Cancer Center1 site in 1 country50 target enrollmentMay 2015
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Case Comprehensive Cancer Center
Enrollment
50
Locations
1
Primary Endpoint
The effect of art therapy on the cancer patient's pain
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Participants in this research study are asked to tell about their experience with art therapy. Participants in this research study are currently receiving chemotherapy treatment for cancer. The purpose of this study is to learn how art therapy affects mood, anxiety, pain, and emotions of individuals with cancer who are undergoing chemotherapy.

Detailed Description

In this single-center single-arm non-controlled descriptive study, we aim to describe the effects of a single art therapy session on a cancer patient's mood, pain, anxiety level. Primary Objectives * To assess the effect of art therapy on the cancer patient's mood * To assess the effect of art therapy on the cancer patient's anxiety * To assess the effect of art therapy on the cancer patient's pain Secondary Objectives * To explore differences in response to art therapy by ethnic group, race, age, sex, caregiver support, cancer diagnosis, reason for visit, and marital status * To explore differences in response to art therapy by primary concern expressed by patients during art therapy sessions

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
January 25, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects are able to give informed consent
  • Any cancer diagnosis
  • Actively undergoing any chemotherapy treatment at Maroone Cancer Center
  • Patients who have never utilized art therapy at Maroone Cancer Center
  • Speaks, reads, and writes in English
  • Able and willing to participate in an art therapy session at Maroone Cancer Center

Exclusion Criteria

  • Patients without cancer diagnosis
  • Patients not actively undergoing chemotherapy at Maroone Cancer Center
  • Individuals unable to complete art therapy activities independently due to physical and/or mental impairment
  • Under 18 years of age (minors)
  • Patients who have dementia or a legal guardian
  • Unable to speak, read, and write in English
  • Patients who have previously utilized art therapy at Maroone Cancer Center

Outcomes

Primary Outcomes

The effect of art therapy on the cancer patient's pain

Time Frame: Change from baseline to after intervention, about 50 minutes

The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.

The effect of art therapy on the cancer patient's mood

Time Frame: Change from baseline to after intervention, about 50 minutes

The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.

The effect of art therapy on the cancer patient's anxiety

Time Frame: Change from baseline to after intervention, about 50 minutes

The primary endpoint of the trial is to access the effect of an art therapy session on the patients' mood, anxiety level, and pain. To accomplish this, patients will complete four visual analog scales (VAS) prior to and after the session. The primary end points are the pre-and post session changes in the VAS.

Secondary Outcomes

  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and ethnic group of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and age of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and sex of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and cancer diagnosis of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and reason for visit of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and primary concern expressed by patients during art therapy session(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and race of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and caregiver support of patients(Change from baseline to after intervention, about 50 minutes)
  • exploratory assessment of the association between sum of pain, anxiety, and mood visual analog scale (VAS) scores and marital status of patients(Change from baseline to after intervention, about 50 minutes)

Study Sites (1)

Loading locations...

Similar Trials